Cannabis Use Is Associated with Pain Severity and Interference Among Cancer Survivors.

Integrative medicine reports Pub Date : 2024-07-22 eCollection Date: 2024-01-01 DOI:10.1089/imr.2024.0001
Shannon Nugent, Emile Latour, Jeong Lim, Jackilen Shannon, Benjamin J Morasco
{"title":"Cannabis Use Is Associated with Pain Severity and Interference Among Cancer Survivors.","authors":"Shannon Nugent, Emile Latour, Jeong Lim, Jackilen Shannon, Benjamin J Morasco","doi":"10.1089/imr.2024.0001","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Cannabis use for symptom management among individuals with cancer is increasingly common.</p><p><strong>Objectives: </strong>We sought to describe the (1) prevalence and characteristics of cannabis use, (2) perceived therapeutic benefits of cannabis use, and (3) examine how use of cannabis was associated with self-reported pain, mood, and general health outcomes in a representative sample of patients treated at a National Cancer Institute (NCI)-designated Oregon Health and Science University Knight Cancer Institute.</p><p><strong>Methods: </strong>We conducted a population-based, cross-sectional survey developed in conjunction with 11 other NCI-designated cancer centers and distributed to eligible individuals. The survey inquired about characteristics of cannabis use, perception of therapeutic benefits, pain, mood, and general health. Responses were population weighted. We examined the association of cannabis use with self-reported pain, mood, and general health using logistic regression controlling for relevant sociodemographic and clinical characteristics.</p><p><strong>Results: </strong>A total of 523 individuals were included in our analytic sample. A total of 54% endorsed using cannabis at any time since their cancer diagnosis and 42% endorsed using cannabis during active treatment. The most commonly endorsed reasons for use included the following: sleep disturbance (54.7%), pain (47.1%), and mood (42.6%). We found that moderate pain was associated with more than a twofold (odds ratio = 2.4 [95% confidence interval = 1.3-4.6], <i>p</i> = 0.002) greater likelihood of self-reported cannabis use. Depressed mood and general health were not associated with cannabis use.</p><p><strong>Conclusions: </strong>In a state that had early adoption of medical and recreational cannabis legislation, a high number of cancer survivors report cannabis use. Moderate or more severe pain was associated with an increased likelihood to use cannabis, while mood and general health were not associated. Oncologists should be aware of these trends and assess use of cannabis when managing long-term symptoms of cancer and its treatments.</p>","PeriodicalId":73395,"journal":{"name":"Integrative medicine reports","volume":"3 1","pages":"81-91"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11290042/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrative medicine reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/imr.2024.0001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Cannabis use for symptom management among individuals with cancer is increasingly common.

Objectives: We sought to describe the (1) prevalence and characteristics of cannabis use, (2) perceived therapeutic benefits of cannabis use, and (3) examine how use of cannabis was associated with self-reported pain, mood, and general health outcomes in a representative sample of patients treated at a National Cancer Institute (NCI)-designated Oregon Health and Science University Knight Cancer Institute.

Methods: We conducted a population-based, cross-sectional survey developed in conjunction with 11 other NCI-designated cancer centers and distributed to eligible individuals. The survey inquired about characteristics of cannabis use, perception of therapeutic benefits, pain, mood, and general health. Responses were population weighted. We examined the association of cannabis use with self-reported pain, mood, and general health using logistic regression controlling for relevant sociodemographic and clinical characteristics.

Results: A total of 523 individuals were included in our analytic sample. A total of 54% endorsed using cannabis at any time since their cancer diagnosis and 42% endorsed using cannabis during active treatment. The most commonly endorsed reasons for use included the following: sleep disturbance (54.7%), pain (47.1%), and mood (42.6%). We found that moderate pain was associated with more than a twofold (odds ratio = 2.4 [95% confidence interval = 1.3-4.6], p = 0.002) greater likelihood of self-reported cannabis use. Depressed mood and general health were not associated with cannabis use.

Conclusions: In a state that had early adoption of medical and recreational cannabis legislation, a high number of cancer survivors report cannabis use. Moderate or more severe pain was associated with an increased likelihood to use cannabis, while mood and general health were not associated. Oncologists should be aware of these trends and assess use of cannabis when managing long-term symptoms of cancer and its treatments.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用大麻与癌症幸存者的疼痛严重程度和干扰有关。
背景:在癌症患者中,使用大麻控制症状的现象越来越普遍:我们试图描述:(1) 使用大麻的流行率和特征;(2) 使用大麻的治疗效果;(3) 研究在美国国家癌症研究所(NCI)指定的俄勒冈健康与科学大学奈特癌症研究所接受治疗的代表性样本患者中,使用大麻与自我报告的疼痛、情绪和一般健康结果之间的关系:我们与 NCI 指定的其他 11 家癌症中心联合开展了一项基于人群的横断面调查,并分发给符合条件的个人。调查询问了使用大麻的特征、对治疗效果的看法、疼痛、情绪和总体健康状况。对回答进行了人口加权。我们使用逻辑回归法研究了大麻使用与自我报告的疼痛、情绪和一般健康状况之间的关系,并对相关的社会人口学和临床特征进行了控制:结果:共有 523 人被纳入我们的分析样本。共有 54% 的人认可在确诊癌症后的任何时间使用过大麻,42% 的人认可在积极治疗期间使用过大麻。最常见的使用原因包括:睡眠障碍(54.7%)、疼痛(47.1%)和情绪(42.6%)。我们发现,中度疼痛与自我报告使用大麻的可能性增加两倍多(几率比 = 2.4 [95% 置信区间 = 1.3-4.6],p = 0.002)有关。抑郁情绪和一般健康状况与吸食大麻无关:在一个较早通过医疗和娱乐大麻立法的州,有很多癌症幸存者报告使用大麻。中度或更严重的疼痛与使用大麻的可能性增加有关,而情绪和总体健康状况与之无关。肿瘤学家应了解这些趋势,并在处理癌症及其治疗的长期症状时评估大麻的使用情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluating the Current Evidence for the Efficacy of Cannabis in Symptom Management of Endometriosis-Associated Pain. Investigating the Impacts of a Modified Mindfulness Practice on Minoritized College Students' Chronic Stress. Cannabis Use Is Associated with Pain Severity and Interference Among Cancer Survivors. Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19: A Prospective, Longitudinal, Descriptive Cohort Study Protocol Medical Cannabis Use Among Canadian Veterans and Non-Veterans: A National Survey.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1